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Abstract Mantle cell lymphoma (MCL) is a rare, specific
lymphoma subtype. Though the morphologic and immuno-
phenotypic features of MCL have been well described in
recent literatures, it is still a diagnostic dilemma because of
its frequent confusion with other small B cell lymphomas
(SBCLs). In the present study, we primarily focus on
establishing a sensitive and specific method for the
diagnosis of MCL, which is efficient to distinguish this
disease from other SBCLs. We carried out our investigation
for MCL and other SBCLs (including SLL, FL, MZL, and
MALT) on their feature of morphology, immunophenotype,
and t(11;14)(q13;q32) translocation analysis based on
polymerase chain reaction (PCR) and interphase nuclei
micro-array fluorescence in situ hybridization (FISH). The
morphologic and immunologic analysis showed the posi-
tive rate of cyclin D1 was 76.47% in MCL, which was
significantly higher than that in other SBCLs. The positive
rate of t(11;14) translocation was 25.81% and 35.48%,
respectively, tested by general and semi-nested PCR, while
93.10% positive rate was shown with low background and
strong signals pattern when tested by Nuclei micro-array
FISH. Our research shows that t(11;14) translocation is a
special and useful diagnostic marker for MCL, and
detection of the marker by nuclei micro-array FISH is
convenient and economic, especially more sensitive and
specific than other methods for the diagnosis of MCL.
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Mantle cell lymphoma (MCL) is a distinctive disease entity,
accounting for approximately 3% to 10% of non-Hodgkin’s
lymphomas. Unlike other SBCLs, MCLs generally manifest
aggressive clinical course with a median survival of only 3
to 5 years, while many are refractory to conventional
therapy [1]. Due to widely different therapeutic regimens
and prognosis, the differential diagnosis of MCL to other
SBCLs is critical. Three different architectural patterns of
MCL exist, including mantle zone, nodular, and diffuse
pattern [2], which may be confused in morphology with
other small B cell lymphomas (SBCLs), making it difficult
to diagnose based purely on morphology. Immunohisto-
chemistry may be helpful in some cases [3], but false-
negative or false-positive results can also lead to confusion
due to the variable immunophenotype and/or poor quality
of the tissue that acquired. Therefore, morphology and
immunophenotype alone are not sufficient enough to
establish the definitive diagnosis of MCL. Recent studies
concentrate on the specificity of molecular genetics t(11;14)
(q13;q32), which is characteristic of MCL [4] and can be
detected by cytogenetic techniques, including polymerase
chain reaction (PCR) and fluorescence in situ hybridization
(FISH). However, conventional cytogenetic techniques
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DOI 10.1007/s00277-011-1197-0PCR are less useful because of the variability of break-
points, which results in low sensitivity [5]. So, FISH is the
most sensitive technique for demonstrating the chromo-
some translocation. In this study, we introduced a new
FISH procedure to establish a sensitive and effective
method for the diagnosis and differential diagnosis of
MCL in clinical laboratories.
Materials and methods
One hundred and eighteen cases of MCL and other SBCLs
diagnosed during the period 2002 to 2006, in the Pathology
Department of the Affiliated Nanfang Hospital of Southern
Medical University, were reviewed on the basis of
morphologic and immunophenotyping studies. Lymphoma
cases were diagnosed according to the criteria from the new
World Health Organization and classified by two separate
expert hematopathologists.
Morphology
For morphologic interpretation, 2-μm sections taken from
10% neutral buffered formalin-fixed, paraffin-embedded
tissue were routinely stained with H&E. The slides with
tissues of MCL were evaluated for the pattern of involve-
ment (mantle zone, nodular, or diffuse), as previously
described [6].
Immunohistochemistry
Ninety-one of the 118 cases were stained with a panel of
antibodies including CD20, CD10, CD5, Bcl-2, CD23, and
cyclin D1 (Dako), using standard technique as described in
other literature [7] with slight refining. For cyclin D1
staining, antigen retrieval was performed with 0.1 mmol/L
ethylenediaminetetraacetic acid (EDTA) and with pH 8.0
for 13 min at 121°C in an autoclave, and before antigen
retrieval, the slides were predigested in 0.4% pepsin.
Primary antibodies were incubated in a humidified chamber
overnight at 4°C, and appropriate positive and negative
controls were set throughout the study.
Molecular biology
Detection of t(11;14) translocation by PCR
In total, 73 cases were selected for PCR study. Genomic
DNA was extracted from paraffin-embedded tissue sections
by the standard method described previously [8]. Both
common and semi-nested PCR were introduced to detect
the t(11;14) translocation. PCR primers directed to detect
breakpoints within the major translocation cluster (MTC)
were selected and performed as previously described[9].
For common PCR, a definite and sharp single band about
150–350 bp on 2% agarose gel is considered as positive,
and for semi-nested PCR, a definite and clear single band
about 180–250 bp on 2% agarose gel is positive.
Detection of t(11;14) translocation by FISH
Nuclei were extracted according to the method described
previously [10] with slight modification. Instead of room
temperature, water bath heating was applied for dewaxing.
When the nuclei suspensions were ready, a micro-array map
with a grid of 0.3 cm in diameter was made using a
computer, a poly-L-lysine-coated slide was put on the
micro-array map and the nuclei suspensions were dropped
in accordance with the grid in the map, and then the slide
were stored at room temperature for drying and eventually
stored at 4°C for the following experiments.
FISH for detection of t(11;14) translocation was
performed on nuclei micro-array slides using commercially
available LSI IgH/CCND1 dual-color, dual-fusion translo-
cation probe, which was a mixture of the LSI IgH probe
labeled with Spectrum Green and the LSI CCND1 probe
labeled with Spectrum Orange (Vysis). The nuclei micro-
array slides were pretreated as described previously [11].
Hybridization was processed by diluting probe in hybrid-
ization buffer (Vysis, Downers Grove, IL, USA) and
incubation at 82°C for 10 min and at 37 C overnight. After
hybridization, the samples were strictly washed as de-
scribed by manufacturer and then counterstained with DAPI
(Vysis). Finally, the specimen slides were evaluated under
fluorescent microscope. At least 100–200 non-overlapping,
intact nuclei were scored, and nuclei were counted only
when they contained at least one bright-green signal and
one bright-orange signal to avoid insufficient hybridization
efficiency. Appropriate positive and negative controls were
included. The cut-off level for the diagnosis of fusion was
obtained from the results of the hybridization with chronic
tonsillitis (mean ± 3 standard deviation).
Statistics
The data were collected and statistically analyzed using the
Statistical Package SPSS, VERSION 13.0 software program.
P values of <0.05 was considered statistically significant.
Results
Morphology
One hundred and eighteen cases consisting of 39 MCL
(here, we choose only SBCLs as the research subject,
1300 Ann Hematol (2011) 90:1299–1305among which, the proportion of MCL is much higher than
that in general lymphomas), 19 B cell small lymphocytic
lymphoma (B-SLL), 24 follicular lymphoma (FL), 11
marginal zone lymphoma (MZL), and 25 mucosa-
associated lymphatic tissue (MALT) were confirmed with
morphologic analysis. Patients were mostly in middle age
or elderly adults with a male predominance. The main
initial characteristics of the 118 patients were detailed in
Table 1. For patients with MCL, the patterns of involve-
ment included mantle zone (11 cases), nodular (12 cases),
and diffuse (16 cases). Cases of MCL showed monotonous
population of cells with small slightly cleaved nuclei, which
showed morphologic features that overlap with other
SBCLs. (Fig. 1).
Immunohistochemistry
Only 91 of the 118 cases were performed with immuno-
histochemical studies due to the lack of sufficient materials
(including five MCL cases). Among the 34 MCL cases that
were assessed for immunohistochemistry, 26 (76.47%)
were reactive to cyclin D1 with moderate to strong intensity
staining, the positive rate was significantly higher than in
other SBCLs whereas some other SBCLs also showed
cyclin D1 expression with weak/negative intensity. Our
study showed that CD5 expression in MCL and B-SLL was
low and only 19 of 34 cases (55.88%) of MCL and three of
ten of B-SLL were positive for CD5, lower than in other
reports. Six of ten cases (60%) of B-SLL that were
performed on immunohistochemistry showed CD23 ex-
pression, which could also be detected in some MALT
cases, but the remaining cases were negative for the CD23
antigen. CD10 was mainly detected in FL except for one
MZL. None of the other cases was positive for CD10
expression. Bcl-2 was variably expressed in different types
of the above lymphomas (Fig. 2).
Molecular biology
Some cases were not fit for PCR analysis to be performed
on because of poor DNA quality. Of the 73 cases that were
tested for t(11;14) translocation by PCR, only the cases of
Table 1 Clinical features of small B cell lymphomas
Characteristics MCL (N=39) B-SLL (N=19) FL (N=24) MALT (N=25) MZL (N=11)
Sex (male/female) 31/8 11/8 15/9 15/10 9/2
Age (range (mean)) 23–72 (58.36) 16–73 (50.58) 26–79 (52.38) 13–81 (51.48) 36–76 (58.82)
Age≧60 21 11 9 8 7
Localization (nodal/extranodal) 26/13 7/12 19/5 1/24 3/8
MCL mantle cell lymphoma, FL follicular lymphoma, B-SLL B cell small lymphocytic lymphoma, MZL marginal zone lymphoma, MALT
mucosa-associated lymphatic tissue
Fig. 1 Histological features of
MCL and other similar small B
cell lymphomas. MCL, MALT,
B-SLL, and FL were shown to
contain a monotonous popula-
tion of cells with similar slightly
cleaved nuclei (H&E ×400)
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while the others were negative. Eight of 31 (25.81%) MCL
were positive for t(11;14) translocation by common PCR,
while 13 of 31 (35.48%) MCL were positively detected by
semi-nested PCR (Fig. 3). Of the eight positive cases
showing t(11;14) translocation by common PCR, seven
were also positive for t(11;14) translocation in semi-nested
PCR studies while the remaining one was negative. Though
semi-nested PCR had greater sensitivity, there was no
statistically significant difference between the two methods,
p=0.409 (p>0.05).
Seven of the 73 cases including two MCL, four B-SLL,
and one MALT failed to have been extracted adequate
nuclei to make nuclei micro-array due to inadequate tissue.
The remaining 66 cases showed that the quality of nuclei
extracted with water bath heating instead of on common
temperature for dewaxing was higher with few foreign
materials, and the nuclei micro-array made by pointing
nuclei on the slides directly was qualified with clear
background and steady nuclei. Among the 66 cases studied
with FISH, two cases with chronic tonsillitis failed to
produce adequate signal for counting. FISH results in
normal lymphocyte nuclei showed the expected two orange
and two green probe signals, while results in tumor cell
nuclei showed one orange probe (CCND1), one green
probe (IgH), and one or two yellow fusion (IgH/CCND)
probe signals patterns (Fig. 4). The t(11;14) translocation
were detected in 27 of 29 (93.10%) cases of MCL with low
background and strong signal patterns, and the fusion
signals were detected in 40–85% of the counted nuclei.
Specifically, three cases of B-SLL were also detected to be t
(11;14) translocation positive, of which, one was weak
positive, one was weak/negative, and one was negative for
cyclin D1expression in prior immunohistochemical studies.
Among the remaining cases that were evaluated, no cases
harbored t(11;14) translocation. Notably, there were two
cases of MCL showing CCND1 gene amplification with
more than three orange signals in one nucleus, and 50–80%
of the counted nuclei showed these amplification signals.
The results of FISH, PCR, and Immunophenotyping of
the 34 cases of MCL are detailed in Table 2.
Discussion
MCL is now recognized as a distinct clinicopathologic
entity. It is a rare type of lymphoma comprising between
5% and 10% of all non-Hodgkin’s lymphomas. It is very
important to recognize this rare lymphoma because of its
poor overall survival rate and limited response to conven-
tional chemotherapy in most cases. Several morphologic
variants have been described, including mantle zone,
nodular, and diffuse growth patterns. Some researches
showed that patients with mantle zone pattern apparently
had a more indolent outcome, while patients with non-
nodal pattern seemed to have a better prognosis when
compared with patients with predominantly nodular pattern
[12]. In our study, the patterns of involvement included
Fig. 2 Immunohistochemical staining for cases of MCL (magnification, ×400)
Fig. 3 Detection of t(11;14) translocation by PCR. M DNA marker,
100 bp. a Common PCR: lanes 1–3 and 5–9 were cases of MCL; lane
4 was negative control; lanes 1–3, 5–7, and 9 show a sharp single-
positive band about 150–350 bp. b Semi-nested PCR: lanes 1–3 and
5–9 were cases of MCL; lane 4 was negative control; lanes 1–3 and
6–9 show a clear single band about 180–250 bp
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mantle zone (11 cases), nodular (12 cases), and diffuse
(16 cases), but we failed to proceed with the analysis due to
semi-complete clinical data. Our study also showed cases of
MCL having morphologic overlaps with other SBCLs,
making the primary diagnosis and subclassification based
on morphology alone a diagnostical challenge. Thus, theavailability of immunohistochemical markers is mandatory
for the diagnosis. Positive cyclin D1 staining is a hallmark
of MCL, and coexpression of cyclin D1 and CD5 can
distinguish MCL from other SBCLs [13]. However, a
minor proportion of the cases may fail to express cyclin D1
[14]. Clinically similar to the cases with cyclin D1
expression, the negative cases expressing cyclin D2 or
cyclin D3 while maintaining the gene expression profile are
common to the cyclin D1-positive MCL. In this situation,
the absence of CD23 distinguishes MCL from B-SLL, and
the presence of CD5 distinguishes MCL from FL and MZL
[15]. However, expression of CD23 can be observed in a
subset of MCL, which leads to diagnostic confusion [16].
Moreover, the results of immunophenotype are variable and
sometimes may be false negative, mainly due to the quality
of the material. In our study, though the detection rate of
cyclin D1 can be improved by performing antigen retrieval
by boiling in EDTA and predigesting in 0.4% pepsin before
antigen retrieval, the positive rate still remains 76.47%,
only a little higher than that in other report [5]. The
negative results usually made us confused, and it was hard
to determine whether they were true or false negative due to
various staining with different fixation. Obviously, immu-
nohistochemistry alone is not sufficient to establish a
definitive diagnosis, and molecular analysis may be crucial
for the diagnosis.
The hall marker of MCL is t(11;14) translocation, which
is virtually present in all MCL, rarely involved with other
lymphoma types [17]. Some researches used different
methods to detect this translocation [18], but each of the
methods had some shortages. Conventional cytogenetics,
which requires more time and fresh tissue, may not be
readily available to all practitioners. Archival materials in
our study are not fit for those traditional methods. PCR is
an efficient method with fast speed but sometimes with
relatively low specificity and sensitivity. In the present
study, both common and semi-nested PCR were performed
to detect t(11;14) translocation, the positive rate were
25.81% and 35.48%, respectively, lower than the 50.00%
that was reported in other literature [19]. This low
sensitivity may be due to the specific chromosomal
translocation, in which the actual breakpoints scattered
Fig. 4 a Chronic tonsillitis case
showing normal signal patterns
with two green and two orange
signals, ×630. b Case of MCL
showing abnormal signal pat-
terns with colocalization of green
and orange signals, ×630
Table 2 Results of FISH, PCR, and Immunophenotyping study in
MCL
Patient no. FISH t(11;14)
(q13;q32)
PCR t(11;14)(q13;q32) Cyclin D1
staining
Common Semi-nested
1 Positive Negative Negative Positive
2 Positive Negative Negative Positive
3 Positive Negative Negative Negative
4 Failed Negative Negative Positive
5 Positive Positive Positive Positive
6 Not do Not do Not do Negative
7 Not do Not do Not do Positive
8 Positive Negative Positive Positive
9 Positive Negative Negative Positive
10 Positive Negative Positive Positive
11 Positive Negative Positive Positive
12 Positive Negative Negative Positive
13 Positive Negative Negative Negative
14 Positive Negative Negative Positive
15 Positive Positive Positive Positive
16 Positive Negative Negative Positive
17 Not do Not do Not do Negative
18 Positive Positive Positive Positive
19 Positive Negative Positive Positive
20 Positive Positive Positive Positive
21 Failed Negative Negative Negative
22 Positive Positive Positive Positive
23 Positive Negative Positive Positive
24 Positive Negative Negative Positive
25 Positive Positive Positive Positive
26 Positive Negative Negative Positive
27 Positive Negative Negative Positive
28 Positive Negative Negative Positive
29 Positive Positive Negative Positive
30 Positive Negative Negative Positive
31 Positive Positive Positive Positive
32 Negative Negative Negative Negative
33 Negative Negative Negative Negative
34 Positive Negative Positive Negative
FISH fluorescence in situ hybridization, PCR polymerase chain
reaction
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Although the great majority of these breakpoints are located
within a segment of about 100 bp located around the MTC,
there are still some cases with breakpoints out of the MTC
[20]. Thus, PCR analysis may give false-negative results.
FISH with great value in cytogenetic studies is applied in
many researches. It shows highly specific and sensitive, but
the expensive probes make it unpractical to routine
application. In this study, we made an ideal result by
performing FISH on nuclei micro-array, which was estab-
lished and reported by our research team in detection of t
(14;18) in FL. By performing FISH on nuclei micro-array
slides, many cases could be finished simultaneously on a
single slide with high comparability and little variance,
making it more simple, rapid and inexpensive to be carried
out. With some improvement, such as extracting nuclei by
water bath heating for dewaxing, we obtained intact nuclei
with few foreign materials. Meanwhile, by pointing nuclei
on the slides directly to substitute the cell micro-array
molds that were reported in our previous study [10], we
made perfect nuclei micro-arrays with clear background
and steady nuclei more easily and simply. Using this new
method, we detected t(11;14) translocation in 27/29 of
MCL with low background and strong signal patterns. The
positive rate was 93.10%, which was significantly higher
than that of immunohistochemistry or PCR analysis. In fact,
the two negative cases were abnormal and not suitable for
this type of situation. Some cases showed typical features
of MCL in morphology analysis, while the immunopheno-
typing results were confusing. They were positive for CD5,
but cyclin D1 and CD23 were both negative. For some
cyclin D1-negative cases of MCL reported in other study
[21], they both were classified to MCL based on morphol-
ogy. However, t(11;14) translocation was not detected in
these cases by nuclei micro-array FISH, so genuine MCL or
not of these cases were questioned. Therefore, nuclei micro-
array FISH is the most sensitive technique when compared
with immunohistochemistry and PCR. Specifically, the t
(11;14) translocation has been described in other lymphoid
tumors, including hairy cell leukemia and multiple myelo-
ma. In our present study, three cases of B-SLL were also
detected t(11;14) translocation, of which, one was weak
positive, one was weak/negative and one was negative for
cyclin D1 expression and all were weak positive for CD23
expression in prior immunohistochemical studies. Although
there were a few patients with B-SLL/CLL have been
reported to have t(11;14) translocation [22], it was unclear
whether the B-SLL/CLL harboring t(11;14) translocation
represent genuine CLL or MCL. Moreover, expression of
CD23 can be observed in a subset of MCL [16], so, the
three B-SLL with t(11;14) translocation positive might be
MCL indeed. Interestingly, we found two cases with MCL
showed CCND1 gene amplification with more than three
orange signals in one nucleus. The CCND1 gene encodes
for cyclin D1, which has been shown to be expressed even
in cases without t(11;14) translocation. Therefore, it has
been suggested that CCND1could also be activated by
amplification [23], though this requires more studies.
In conclusion, the diagnosis of MCL is often a dilemma
and requires a combination of morphologic, immunohisto-
chemical, and genetic studies. Our study shows that nuclei
micro-array FISH is convenient and economic, suitiable for
routine detection of MCL t(11;14) translocation in clinical
laboratory, making it a promising and desirable alternative
for MCL diagnosis.
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